World-class money managers like Bill Ackman and Barry Rosenstein only invest their wealthy clients’ money after undertaking a rigorous examination of any potential stock. They are particularly successful in this regard when it comes to small-cap stocks, which their peerless research gives them a big information advantage on when it comes to judging their worth. It’s not surprising then that they generate their biggest returns from these stocks and invest more of their money in these stocks on average than other investors. It’s also not surprising then that we pay close attention to these picks ourselves and have built a market-beating investment strategy around them.
Rentech Nitrogen Partners LP (NYSE:RNF) shares haven’t seen a lot of action during the third quarter. Overall, hedge fund sentiment was unchanged. The stock was in 5 hedge funds’ portfolios at the end of September. At the end of this article we will also compare RNF to other stocks including Opower Inc (NYSE:OPWR), Collegium Pharmaceutical Inc (NASDAQ:COLL), and Aerie Pharmaceuticals Inc (NASDAQ:AERI) to get a better sense of its popularity.
With all of this in mind, we’re going to check out the latest action encompassing Rentech Nitrogen Partners LP (NYSE:RNF).
How have hedgies been trading Rentech Nitrogen Partners LP (NYSE:RNF)?
According to publicly available hedge fund and institutional investor holdings data compiled by Insider Monkey, GLG Partners, managed by Noam Gottesman, holds the largest position in Rentech Nitrogen Partners LP (NYSE:RNF). GLG Partners has a $4.6 million position in the stock, comprising 0.1% of its 13F portfolio. The second most bullish fund manager is Jeff Buick of Trishield Capital Management, with a $2.4 million position; the fund has 2.6% of its 13F portfolio invested in the stock. Remaining members of the smart money that hold long positions include Jim Simons’s Renaissance Technologies, Gavin Saitowitz and Cisco J. del Valle’s Springbok Capital and Marc Lehmann’s Riverloft Capital Management.